Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...

A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

A study demonstrates the role of the Galectin-1 protein in the nucleus of the cells surrounding the tumor -- fibroblasts -- contributing to their activation. Activated fibroblasts promote tumor growth ...

Researchers have developed a cutting-edge chip technology capable of precisely mimicking the interactions between cancer cells and blood vessels, akin to the human body environment. This innovation is ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

A new research perspective was published in , Volume 16, on April 4, 2025, titled "GSK3β activation is a key driver of ...

Kanazawa University, report in Nature Communications how the targeted suppression of lysosome function may lead to brain ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

The double ring, spool-like structure of RAD52 protects replicating DNA in dividing cells. A study led by the University of ...

A phase 3 trial of nemvaleukin alfa in with Keytruda for patients with platinum-resistant ovarian cancer will not continue on ...

Causes of glioblastoma are not known, and there is no method for preventing the cancer. Traditional treatment includes the drug temozolomide (TMZ). In many cases, TMZ kills glioblastoma cells, but a ...